ITUS Corp (ITUS.OQ)
ITUS.OQ on NASDAQ Stock Exchange Capital Market
4.03USD
20 Apr 2018
4.03USD
20 Apr 2018
Change (% chg)
$-0.07 (-1.71%)
$-0.07 (-1.71%)
Prev Close
$4.10
$4.10
Open
$4.10
$4.10
Day's High
$4.10
$4.10
Day's Low
$3.96
$3.96
Volume
14,543
14,543
Avg. Vol
120,403
120,403
52-wk High
$6.42
$6.42
52-wk Low
$0.60
$0.60
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Amit Kumar |
53 | 2017 | Chairman of the Board, President, Chief Executive Officer |
Michael Catelani |
50 | 2017 | Chief Financial Officer, Chief Operating Officer |
Arnold Baskies |
68 | 2016 | Director |
Dale Fox |
50 | 2014 | Independent Director |
John Monanhan |
70 | 2016 | Independent Director |
- BRIEF-Itus Corp - Co Entered Into An At Market Issuance Sales Agreement With B. Riley FBR, Inc
- BRIEF-Itus And Serametrix Announce Results Of A Blinded Prostate Cancer Study
- BRIEF-Itus Announces Issuance Of Second Key Cancer Detection Technology Patent
- BRIEF-Itus Corp Forms Alliance With Serametrix Corp
- BRIEF-Lewis Titterton Reports 6.6 Pct Stake In Itus Corp As Of Feb. 14, 2018